How to Get Away from the Immune System

From manipulating host molecules to concealing their presence in the host’s body, microbes employ a wide range of tactics to dodge immune detection.

Written byMariella Bodemeier Loayza Careaga, PhD
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The immune system is highly trained to detect and eliminate any potential threat to the human body. While years of evolution have turned this system into a pathogen-killing machine, the microbes it fights have also evolved intricate strategies to evade it.

A Parasite and the Art of Cloaking

On the left, several red blood cells are shown sticking to blood vessel walls, with grey malaria parasites within them. On the right, a graph shows how parasitemia rises and falls over time as the parasite uses different forms of PfEMP1.
modified from © istock.com, Shivendu Jauhari, Irfan Setiawan, Eranicle

1) The malaria parasite Plasmodium falciparum expresses the protein PfEMP1 on the surface of erythrocytes to adhere the cells to blood vessel walls and escape clearance by the spleen.

2) PfEMP1 can be detected by immune cells. Through the process of antigenic variation, P. falciparum expresses different versions of it and escapes immune recognition.

Controlling the Enemy Within

On the left, Mycobacterium tuberculosis bacteria enter a macrophage and pathways by which the bacteria avoid destruction, and how they disrupt communication between the macrophage and a T cell (shown on the right) are depicted.
modified from © istock.com, ttsz

3) Inside macrophages, Mycobacterium tuberculosis dodges intracellular degradation by secreting virulence factors. Two effectors, EsxH and EsxG, inhibit the function of the ESCRT machinery, impairing the maturation of bacteria-carrying phagosomes.

4) Another Mycobacterium virulence factor, CpsA, disrupts another degradation pathway and blocks the activity of NADPH oxidase, impairing the destruction of the bacteria.

5) By affecting the normal function of ESCRT, M. tuberculosis EsxH-EsxG complex also disturbs the process of antigenic presentation via the MHC-II molecule.

A Viral Manipulator

On the left, HIV disrupts surface expression of MHC proteins in a T cell; HIV also impairs communication between T cells and an antigen-presenting cell, shown on the right.
modified from © istock.com, ttsz, bombuscreative

6) To stay hidden inside lymphocytes, HIV-1 expresses viral factors such as the negative factor (Nef) protein. In the infected cell, Nef downregulates the expression of MHC-I and MHC-II on the cell surface, impairing the presentation of viral antigens.

7) Nef also disrupts the proper formation of immunological synapses, the points of communication between T cells and antigen-presenting cells.

A Temporary Fungal Shield

on the left, a pink Candida albicans cell is shown. A section of the cell wall is enhanced to show how the beta-glucans, shown in green, are covered by mannans, shown in blue. On the right, macrophages recognize beta-glucans.
modified from © istock.com, ttsz, KKT Madhusanka

8) In Candida albicans, beta-glucans are a major target for immune detection by macrophages, which are one of the first lines of immune defense. The fungus covers its beta-glucans with a layer of mannans, shielding them from macrophage detection to prolong their stay in the host.

Read the full story.

  1. Deitsch KW, Dzikowski R. Variant gene expression and antigenic variation by malaria parasites. Annu Rev Microbiol. 2017;71:625-641.
  2. Chandra P, et al. Immune evasion and provocation by Mycobacterium tuberculosis. Nat Rev Microbiol. 2022;20(12):750-766.
  3. Fackler OT, et al. Modulation of the immunological synapse: A key to HIV-1 pathogenesis?. Nat Rev Immunol. 2007;7(4):310-317.
  4. Gow NAR, Lenardon MD. Architecture of the dynamic fungal cell wall. Nat Rev Microbiol. 2023;21(4):248-259.
  5. Gilbert AS, et al. Fungal pathogens: Survival and replication within macrophages. Cold Spring Harb Perspect Med. 2014;5(7):a019661.

Related Topics

Meet the Author

  • Black and white portrait by Mariella Bodemeier Loayza Careaga, PhD

    Mariella joined The Scientist in 2023. Before that, she was a postdoctoral researcher at the Uniformed Services University of the Health Sciences studying sex differences on the effects of chronic stress and traumatic brain injury. Mariella holds a master’s and a PhD in neuroscience from the Universidade Federal de Sao Paulo, Brazil, and a certificate in Science Communication from the University of California, San Diego.

    View Full Profile

Published In

The Scientist Winter issue cover 2024
December 2024

Detection or Deception: The Double-Edged Sword of AI in Research Misconduct

New artificial intelligence tools help scientists fight back against a rising tide of research misconduct, but is it enough?

Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies